Description

Tune in to hear PwC Deals leaders discuss preparing for deals in 2024, exploring the current state of the deals market and sharing valuable insights from their newly released 2024 deals outlook. Key topics include:

• Fundamental changes and strategy trends for 2024 and how it’s shaping the health services and pharma landscapes
• The role of the regulators and their impact on deals
• Business model reinvention and the use of new technology to acquire better data and how it’s shaping the deals environment for 2024
• What’s on the horizon: Key success factors for good deal making in 2024

Speakers:
Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
Nick Donkar, Health Services Deals Leader, PwC
Jenny Colapietro, Health Industries Vice Chair, PwC 
Igor Belokrinitsky, Strategy& Principal, PwC 

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.